Enanta Pharmaceuticals CEO Jay Luly announces retirement by February 1, 2027
ENTA•Enanta Pharmaceuticals CEO Jay R. Luly, 70, will retire by February 1, 2027, after 23 years of leadership and serve as a strategic advisor for the rest of 2027. The board has begun a successor search, and Tara L. Kieffer was appointed chief operating officer.
1. Leadership transition
Enanta Pharmaceuticals President and CEO Jay R. Luly will retire by February 1, 2027, after 23 years leading the company. He will serve as a strategic advisor for the remainder of 2027 to support the transition. The board has launched a search for his successor, considering internal and external candidates.
2. New operating chief
Tara L. Kieffer, most recently chief product strategy officer, was appointed to the newly created chief operating officer role. She joined Enanta in 2020 after a 16-year career at Vertex Pharmaceuticals spanning research, clinical development and business functions.
